Physician profile
Daniel T Colombo
NPI 1568750933
$611.95
in general payments reported to CMS, 2019-2025
13 companies · $138 in 2025
The $138 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $191 · 2024: $283 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $127.02 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $100.49 | 2023-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Myriad Women'S Health, INC. | $87.40 | 2023 | Myrisk |
| Glaxosmithkline, LLC. | $63.00 | 2023-2024 | Bexsero, Pediarix, Shingrix |
| Novo Nordisk INC | $52.10 | 2024 | |
| Pfizer INC. | $40.49 | 2023-2025 | |
| Organon LLC | $25.80 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.87 | 2025 | |
| Dexcom, INC. | $21.73 | 2024 | Dexcom G6 Transmitter |
| Kaleo, INC. | $21.11 | 2023 | Auvi-Q |
| Alk-Abello, INC | $19.31 | 2025 | Neffy |
| Gynesonics, INC. | $16.13 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Seqirus USA INC | $15.50 | 2024 | Fluad, Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Colombo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.